Finally, the effect of LXRα on cardiac hypertrophy is heart-specific and independent of confounding systemic effects attributed to either T09 activation, which are lipogenic [102], anti-inflammatory [142], and blood pressure-lowering [75] effects, or residual effects from whole-body LXRα deletion [73]. This evidence concerns the gene NR1H3 and cardiac hypertrophy.